หน่วยสนับสนุนการขอทุนวิจัยจากแหล่งทุนต่างประเทศ

Funding Opportunities

FOA Title Open Date Application Due Date
RFA-DK-20-022 Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) Feb 3, 2021 Mar 3, 2021; Nov 17, 2021
RFA-AI-20-057 Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) Jan 22, 2021 Feb 22, 2021
RFA-AI-20-055 Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) Jan 11, 2021 Feb 11, 2021
RFA-MH-20-556 BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) Jan 11, 2021 Feb 11, 2021; Oct 19, 2021
PAR-20-295 Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) Jan 10, 2021 Feb 10, 2021; Oct 13, 2021
RFA-AI-20-064 A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) Jan 8, 2021 Feb 8, 2021
RFA-AI-20-060 Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) Jan 4, 2021 Feb 4, 2021
RFA-CA-20-043 Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) Dec 20, 2020 Jan 20, 2021
RFA-MH-20-701 Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) Dec 8, 2020 Jan 8, 2021
RFA-MH-20-702 Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) Dec 8, 2020 Jan 8, 2021
RFA-CA-20-045 Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) Nov 16, 2020 Dec 16, 2020
RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Nov 13, 2020 Dec 15, 2020; Dec 14, 2021
PAR-20-299 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) Nov 10, 2020 Dec 10, 2020;
Apr 9, 2021;
Aug 10, 2021;
Dec 10, 2021;
Apr 11, 2022;
Aug 10, 2022;
Dec 9, 2022
PAR-20-300 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Nov 10, 2020 Dec 10, 2020;
Apr 9, 2021;
Aug 10, 2021;
Dec 10, 2021;
Apr 11, 2022;
Aug 10, 2022;
Dec 9, 2022
RFA-HD-21-030 Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) Nov 10, 2020 Dec 10, 2020
RFA-HD-21-006 Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) Oct 30, 2020 Nov 30, 2020
PAR-20-273 New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) Oct 18, 2020 Nov 8, 2020; Aug 11, 2021; Nov 18, 2021; Aug 11, 2022; Nov 18, 2022; August 11, 2023
PAR-20-274 New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 – Clinical Trial Optional ) Oct 18, 2020 Nov 8, 2020; Aug 11, 2021; Nov 18, 2021; Aug 11, 2022; Nov 18, 2022; August 11, 2023
PAR-20-294 Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Oct 12, 2020 Nov 12, 2020;
Apr 9, 2021;
Nov 9, 2021;
Apr 7, 2022;
Nov 9, 2022
RFA-DE-21-001 Characterizing causal mechanisms to prevent dental fear and anxiety (R01 Basic Experimental Studies with Humans Required) Oct 10, 2020 Nov 10, 2020
RFA-CA-20-034 NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed) Oct 9, 2020 Nov 9, 2020
RFA-DA-21-013 Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 – Clinical Trial Optional) Oct 7, 2020 Nov 6, 2020
PAR-20-284 Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) Oct 4, 2020 Nov 4, 2020;
May 6, 2021;
Nov 4, 2021;
May 5, 2021;
Nov 3, 3022;
May 4, 2023
RFA-HG-20-044 Defining Genomic Influence on Gene Network Regulation (U01 Clinical Trial Not Allowed) Oct 4, 2020 Nov 4, 2020
RFA-HG-20-047 Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed) Oct 4, 2020 Nov 4, 2020
PAR-20-182 Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 – Clinical Trial Not Allowed) Sep 30, 2020 Oct 30, 2020
PAR-20-241 Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 – Clinical Trial Not Allowed) Sep 30, 2020 Oct 30, 2020
RFA-HG-20-048 Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01 Clinical Trial Optional) Sep 28, 2020 Oct 28, 2020;
Jul 8, 2021
RFA-HG-20-049 Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21 Clinical Trial Optional) Sep 28, 2020 Oct 28, 2020;
Jul 8, 2021
RFA-NS-21-006 Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed) Sep 27, 2020 Oct 27, 2020
RFA-NS-21-007 Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) Sep 27, 2020 Oct 27, 2020
PAR-20-292 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Sep 20, 2020 Oct 20, 2020; Feb 19, 2021; Jun 21, 2021; Oct 20, 2021; Feb 22, 2022; Jun 21, 2022
PAR-20-254 Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) Sep 19, 2020 Oct 19, 2020;
Feb 17, 2021;
Jun 17, 2021;
Oct 19, 2021;
Feb 17, 2022;
Jun 17, 2022;
Oct 19, 2022;
Feb 17, 2023;
Jun 19, 2023
PAR-20-255 Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) Sep 19, 2020 Oct 19, 2020;
Feb 17, 2021;
Jun 17, 2021;
Oct 19, 2021;
Feb 17, 2022;
Jun 17, 2022;
Oct 19, 2022;
Feb 17, 2023;
Jun 19, 2023
PAR-20-281 Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) Sep 19, 2020 Standard Dates
PAR-20-282 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) Sep 19, 2020 Standard Dates
RFA-MH-20-500 Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required) Sep 19, 2020 Oct 19, 2020 and
Jun 15, 2021
PAR-20-264 Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) Sep 16, 2020 Standard Dates
PAR-20-277 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Sep 16, 2020 Standard Dates
RFA-DA-21-006 BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 – Clinical Trial Not Allowed) Sep 15, 2020 Oct 15, 2020;
Oct 14, 2021
PAR-20-148 Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) Sep 13, 2020 Oct 13, 2020;
Mar 15, 2021;
Oct 13, 2021;
Mar 15, 2022;
Oct 13, 2022;
Mar 15, 2023
RFA-AI-20-027 Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Sep 9, 2020 Oct 9, 2020
PAR-20-235 Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) Sep 5, 2020 Standard Dates
PAR-20-263 Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) Sep 5, 2020 Standard Dates
PAR-20-271 Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Sep 5, 2020 Standard Dates
PAR-20-276 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Sep 5, 2020 Standard Dates
RFA-AI-20-020 Tuberculosis Research Units (U19 Clinical Trial Optional) Aug 28, 2020 Sep 28, 2020
RFA-CA-20-037 Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) Aug 24, 2020 Sep 24, 2020
RFA-EB-20-002 BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) Aug 14, 2020 Sep 14, 2020
PA-20-149 HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Aug 7, 2020 Standard Dates
PA-20-151 Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Aug 7, 2020 Standard Dates
RFA-FD-21-001 Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required Aug 6, 2020,
Aug 5, 2021
Oct 6, 2020,
Oct 5, 2021
RFA-EB-20-001 BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) Aug 3, 2020 Sep 3, 2020
and
Sep 3, 2021
RFA-MH-20-128 BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) Aug 3, 2020 Sep 3, 2020 and
Sep 2, 2021
RFA-DA-21-005 Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) Jul 13, 2020 Aug 13, 2020
RFA-FD-21-002 Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed Jul 13, 2020 Oct 13, 2020
RFA-AI-20-023 Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed) Jul 3, 2020 Aug 4, 2020
RFA-HG-20-036 Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Jul 3, 2020 Aug 3, 2020;
Mar 8, 2021;
Nov 2, 2021;
Aug 1, 2022;
Mar13, 2023
RFA-HG-20-037 Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Jul 3, 2020 Aug 3, 2020;
Mar 8, 2021;
Nov 2, 2021;
Aug 1, 2022;
Mar13, 2023
RFA-CA-20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) Jun 30, 2020 Jul 31, 2020;
Jul 30, 2021
RFA-CA-20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) Jun 30, 2020 Jul 31, 2020;
Jul 30, 2021
RFA-HD-21-005 Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) Jun 30, 2020 Jul 30, 2020
PAR-20-158 Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Jun 29, 2020 Jul 28, 2020;
Jul 28, 2021;
Jul 28, 2022
RFA-AI-20-010 Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) Jun 29, 2020 Jul 28, 2020
RFA-AI-20-016 Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) Jun 29, 2020 Jul 28, 2020
PAR-20-120 Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) Jun 28, 2020 Jul 28, 2020;
Mar 9, 2021;
Mar 9, 2022
RFA-DA-21-004 Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) Jun 20, 2020 Jul 20, 2020
PAR-20-108 International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) Jun 15, 2020 Jul 15, 2020;

Jul 15, 2021;

Jul 15 2022

RFA-DE-20-006 Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) Jun 8, 2020 Jul 8, 2020
RFA-DE-20-007 Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) Jun 8, 2020 Jul 8, 2020
RFA-AI-20-003 Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) Jun 2, 2020 Jul 2, 2020
PAR-20-234 NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Jun 1, 2020 Jul 1, 2020;
Aug 3, 2020;
Sep 1, 2020;
Oct 1, 2020;
Nov 2, 2020;
Dec 1, 2020;
Jan 4, 2021;
Feb 1, 2021
RFA-AI-20-004 Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed) May 29, 2020 Jun 29, 2020
RFA-HG-20-014 Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) May 25, 2020 Jun 24, 2020;
Feb 1, 2021;
Oct 1, 2021;
Jun 24, 2022
RFA-HG-20-015 Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not allowed) May 25, 2020 Jun 24, 2020;
Feb 1, 2021;
Oct 1, 2021;
Jun 24, 2022
RFA-AI-20-008 Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional) May 23, 2020 Jun 23, 2020
RFA-HG-20-001 Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites (U01 Clinical Trial Not Allowed) May 23, 2020 Jun 23, 2020
RFA-HG-20-002 Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Coordinating Center (U01 Clinical Trial Not Allowed) May 23, 2020 Jun 23, 2020
RFA-AG-21-010 Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) May 17, 2020 Jun 17, 2020
PA-20-146 NIDA Small Research Grant Program (R03 Clinical Trial Required) May 16, 2020 Standard Dates
PA-20-194 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) May 16, 2020 Standard Dates
PA-20-195 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) May 16, 2020 Standard Dates
PA-20-196 NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) May 16, 2020 Standard Dates
PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) May 16, 2020 Standard Dates
PAR-20-140 Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) May 16, 2020 Standard Dates
PAR-20-159 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional) May 16, 2020 Standard Dates
PAR-20-168 Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) May 16, 2020 Standard Dates
RFA-AI-20-019 Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed May 15, 2020 Jun 15, 2020
RFA-HL-21-007 Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional) May 8, 2020 Jun 8, 2020
RFA-HL-21-008 Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) May 8, 2020 Jun 8, 2020
RFA-HL-21-009 Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) May 8, 2020 Jun 8, 2020
PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required) May 5, 2020 Standard Dates
PA-20-184 Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) May 5, 2020 Standard Dates
PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) May 5, 2020 Standard Dates
PAR-20-131 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) May 5, 2020 Standard Dates
PAR-20-137 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) May 5, 2020 Jun 5, 2020 (new) and Jul 5, 2020 (renewal, resubmission, revision);
Oct 5, 2020 (new) and Nov 5, 2020 (renewal, resubmission, revision);
Jun 5, 2021 (new) and Jul 5, 2021 (renewal, resubmission, revision);
Oct 5, 2021 (new) and Nov 5, 2021 (renewal, resubmission, revision);
Jun 5, 2022 (new) and Jul 5, 2022 (renewal, resubmission, revision);
Oct 5, 2022 (new) and Nov 5, 2022 (renewal, resubmission, revision)
PAR-20-155 Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) May 5, 2020 Standard Dates
PAR-20-156 Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional) May 5, 2020 Standard Dates
PAR-20-157 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) May 5, 2020 Standard Dates
PAR-20-165 Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) May 5, 2020 Standard Dates
PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Apr 30, 2020 Applications will be accepted on a rolling basis,
beginning on Apr 30, 2020.
PAR-20-178 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Apr 30, 2020 Applications will be accepted on a rolling basis,
beginning on Apr 30, 2020.
RFA-FD-20-032 CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed Apr 22, 2020 Jun 23, 2020
PAR-20-139 Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Apr 13, 2020 May 13, 2020;
Sep 13, 2020;
Jan 13, 2021;
May 13, 2021;
Sep 13, 2021;
Jan 13, 2022;
May 13, 2022;
Sep 13, 2022;
Jan 13, 2023
PAR-20-054 Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed) Apr 10, 2020 May 11, 2020;
May 11, 2021
PA-20-141 Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) Apr 7, 2020 Standard AIDS Dates
PA-20-144 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) Apr 7, 2020 Standard AIDS Dates
PA-20-145 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) Apr 7, 2020 Standard AIDS Dates
PAR-20-123 Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) Apr 7, 2020 Standard AIDS Dates
PAR-20-127 Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) Apr 7, 2020 Standard AIDS Dates
PAS-20-121 Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) Apr 7, 2020 Standard AIDS Dates
RFA-FD-20-034 Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed Apr 1, 2020 Jun 1, 2020
RFA-CA-20-005 Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trial Optional) Mar 30, 2020 Apr 30, 2020;
Nov 17, 2020
RFA-HG-20-008 Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed) Mar 16, 2020 Apr 15, 2020
RFA-DK-19-036 Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required) Mar 9, 2020 Apr 9, 2020
PAR-20-136 Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Mar 7, 2020 Ap 7, 2020;
Nov 9, 2020;
Apr 9, 2021;
Nov 9, 2021;
Apr 7, 2022;
Nov 9, 2022
RFA-DK-19-029 Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional) Mar 7, 2020 Apr 7, 2020
RFA-AI-19-072 Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) Mar 2, 2020 Apr 1, 2020
RFA-DK-19-024 Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) Mar 1, 2020 Apr 1, 2020
PAR-20-042 NCMRR Early Career Research Award (R03 Clinical Trial Optional) Feb 29, 2020 Mar 30, 2020;

Mar 30, 2021;

Mar 30, 2022

RFA-DK-19-020 Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) Feb 26, 2020 Mar 26, 2020
RFA-NS-20-006 BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) Feb 24, 2020 Mar 24, 2020,

Jun 2, 2020,

Oct 1, 2020,

Feb 2, 2021,

Jun 1, 2021,

Oct 1, 2021,

Feb 1, 2022,

Jun 1, 2022,

Oct 3, 2022

RFA-CA-20-032 Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed) Feb 19, 2020 Mar 19, 2020
RFA-AI-19-065 Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) Feb 18, 2020 Feb 18, 2020
RFA-FD-20-027 Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed Feb 18, 2020 April 22, 2020
PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) Feb 17, 2020 Mar 17, 2020;

Mar 17, 2021

PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) Feb 17, 2020 Mar 17, 2020;

Mar 17, 2021

PAR-20-061 Co-infection and Cancer (R21 Clinical Trial Not Allowed) Feb 17, 2020 Mar 17, 2020;

Thereafter, Standard Dates Apply.

RFA-RM-20-003 Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed) Feb 17, 2020 Mar 17, 2020
RFA-RM-20-004 4DN Centers for Data Integration, Modeling and Visualization (UM1 Clinical Trial Not Allowed) Feb 17, 2020 Mar 17, 2020
RFA-DA-20-022 Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional) Feb 11, 2020 Mar 11, 2020
RFA-MH-20-330 Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) Feb 11, 2020 Mar 11, 2020
RFA-MH-20-331 Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) Feb 11, 2020 Mar 11, 2020
PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) Feb 10, 2020 Mar 17, 2020;

Mar 17, 2021

PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) Feb 10, 2020 Mar 17, 2020;

Mar 17, 2021

PAR-19-344 Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional) Feb 10, 2020 Mar 10, 2020;

Mar 10, 2021;

Mar 10, 2022

PAR-20-062 Co-infection and Cancer (R01 Clinical Trial Not Allowed) Feb 6, 2020 Mar 06, 2020;

Thereafter, Standard Dates Apply.

RFA-MH-20-510 Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Feb 2, 2020 Mar 2, 2020;

Nov 2, 2020

RFA-RM-20-001 Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed) Feb 2, 2020 Mar 3, 2020
RFA-RM-20-005 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) Feb 2, 2020 Mar 2, 2020
PAR-20-074 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Jan 28, 2020 Feb 28, 2020;

Jul 10, 2020;

Oct 27, 2020;

Feb 26, 2021;

Jul 13, 2021;

Oct 26, 2021;

Feb 28, 2022;

Jul 11, 2022;

Oct 28, 2022

RFA-MH-21-100 Fine-Mapping Genome-Wide Associated Loci to Identify Proximate Causal Mechanisms of Serious Mental Illness (R01 Clinical Trial Not Allowed) Jan 28, 2020 Feb 28, 2020
PAR-20-078 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Jan 26, 2020 Feb 26, 2020,

Oct 28, 2020,

Feb 26, 2021,

Oct 28, 2021,

Feb 26, 2022,

Oct 28, 2022

RFA-CA-20-017 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

RFA-CA-20-018 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

RFA-CA-20-019 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

RFA-CA-20-020 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

RFA-CA-20-021 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

RFA-CA-20-022 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Jan 21, 2020 Feb , 2020;

May 28, 2020;

Sep 29, 2020

PAR-20-083 Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional Jan 10, 2020 for Apr 10, 2020 Application Due Date for All Subsequent Application Due Dates,

the Earliest Submission Date will be 90 Days Prior to the Application Due Date.

Apr 10, 2020, by 11:59 PM Eastern Time.

Apr 3, 2021, by 11:59 PM Eastern Time.

Apr 2, 2022, by 11:59 PM Eastern Time.

RFA-RM-19-012 Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Jan 19, 2020 Feb 19, 2020
PAR-19-375 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Jan 16, 2020 Standard Dates
PAR-19-389 Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Jan 16, 2020 Standard Dates
PAR-20-046 NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) Jan 16, 2020 Standard Dates
PAR-20-065 Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 Clinical Trial Not Allowed) Jan 16, 2020 Standard Dates
PAR-20-082 Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) Jan 16, 2020 Standard Dates
PAS-19-391 Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) Jan 16, 2020 Standard Dates
PAS-19-392 Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) Jan 16, 2020 Standard Dates
PAS-19-393 Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) Jan 16, 2020 Standard Dates
PAR-20-026 Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) Jan 15, 2020 Feb 14, 2020;

Sep 15, 2020;

Sep 15, 2021;

Sep 15, 2022

PAR-20-027 Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed) Jan 15, 2020 Feb 14, 2020;

Sep 15, 2020;

Sep 15, 2021;

Sep 15, 2022

RFA-MH-20-326 Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) Jan 13, 2020 Feb 13, 2020
RFA-MH-20-327 Dysregulation and Proximal Risk for Suicide (R01 Clinical Trial Optional) Jan 13, 2020 Feb 13, 2020
RFA-OD-19-028 Tobacco Regulatory Science (R01  Clinical Trial Optional) Jan 13, 2020 Feb 13, 2020

Jul 17, 2020

Feb 13, 2021

RFA-MH-20-305 Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01 Clinical Trial Not Allowed ) Jan 10, 2020 Feb 10, 2020
RFA-MH-20-320 Identification, Validation, and Manipulation of Neural Circuits Related to Mental Illness and Alcohol and Substance Use Disorders in Non-human Primates (R01 Clinical Trial Not Allowed) Jan 10, 2020 Feb 10, 2020
RFA-MH-20-350 Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Jan 10, 2020 Feb 10, 2020;

Oct 9, 2020;

Jun 10, 2021

RFA-MH-20-351 Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) Jan 10, 2020 Feb 10, 2020;

Oct 9, 2020;

Jun 10, 2021

PAR-20-037 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) Jan 8, 2020 Standard Dates
PAR-20-038 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) Jan 8, 2020 Standard Dates
RFA-TR-20-001 Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) Jan 6, 2020 Feb 6, 2020;

Oct 6, 2020;

Oct 6, 2021

PAR-19-377 Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional) Jan 5, 2020 Standard Dates
PAR-19-387 Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Jan 5, 2020 Standard Dates
PAR-20-034 Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Jan 5, 2020 Standard Dates

(The first standard due date for this FOA is February 5, 2020.)

PAR-20-045 NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) Jan 5, 2020 Standard Dates
PAR-20-053 Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Jan 5, 2020 Standard Dates
PAR-20-055 Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) Jan 5, 2020 Standard Dates
RFA-AG-20-016 Lucidity in Dementia (R21 Clinical Trial Optional) Jan 3, 2020 Feb 3, 2020
RFA-AG-20-027 Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed) Jan 3, 2020 Feb 3, 2020
RFA-AG-20-037 Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed) Jan 3, 2020 Feb 3, 2020
RFA-AG-20-038 Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed) Jan 3, 2020 Feb 3, 2020
RFA-AG-20-039 Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Jan 3, 2020 Jan 3, 2020
RFA-AG-20-017 Lucidity in Dementia (R21/R33 Clinical Trial Optional) Jan 3, 2020 Feb 3, 2020
RFA-MH-20-340 Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed) Dec 31, 2019 Jan 31, 2020
RFA-AG-20-036 Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed) Dec 29, 2019 Jan 29, 2020
RFA-FD-20-018 Physiologically-based pharmacokinetic/pharmacodynamic model extrapolation to human from rabbit for ophthalmic drug products (U01) Clinical Trials Not Allowed Dec 26, 2019 Feb 27, 2020
RFA-FD-20-019 Bioequivalence of Topical Products: Elucidating Fundamental Principles of Dermal Pharmacokinetics for Microdialysis or Microperfusion Techniques (U01) Clinical Trials Not Allowed Dec 19, 2019 Feb 27, 2020
RFA-AI-19-059 Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) Dec 17, 2019 Jan 17, 2020
RFA-DA-20-026 Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Dec 15, 2019 Jan 15, 2020
PAR-19-307 Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Dec 13, 2019 Jan 14, 2020;

Jan 14, 2021;

Jan 14, 2022

PAR-20-029 Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) Dec 6, 2019 Jan 7, 2020;

Jan 7, 2021;

Jan 7, 2022

PAR-20-031 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) Nov 20, 2019 Dec 20, 2019;

Nov 30, 2020;

Nov 30, 2021

PAR-20-032 Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) Nov 20, 2019 Dec 20, 2019;

Nov 30, 2020;

Nov 30, 2021

PAR-20-033 Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) Nov 20, 2019 Dec 20, 2019;

Nov 30, 2020;

Nov 30, 2021

PAR-20-030 HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) Nov 15, 2019 Dec 15, 2019;

Dec 3, 2020

PAR-19-376 Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional) Oct 14, 2019 Nov 19, 2019;

Sep 24, 2020

PAR-19-361 Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed) Oct 12, 2019 Nov 12, 2019;

Mar 11, 2020;

Nov 12, 2020;

Mar 11, 2021;

Nov 12, 2021;

Mar 11, 2022

PAR-19-353 Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Sep 21, 2019 Oct 21, 2019;

May 27, 2020;

Oct 21, 2020;

May 27, 2021;

Oct 21, 2021;

May 27, 2022

PAR-19-354 Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Sep 21, 2019 Oct 21, 2019;

May 27, 2020;

Oct 21, 2020;

May 27, 2021;

Oct 21, 2021;

May 27, 2022

PAR-19-356 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Sep 18, 2019 Oct 18, 2019;

Feb 20, 2020;

Jun 19, 2020;

Oct 20, 2020;

Feb 19, 2021;

Jun 21, 2021;

Oct 20, 2021;

Feb 22, 2022;

Jun 21, 2022

PAR-19-309 Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Sep 16, 2019 Standard Dates
PAR-19-311 Mechanisms of Tolerance (R21/R33 – Clinical Trial Required) Sep 16, 2019 Standard Dates
PAR-19-346 Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Sep 16, 2019 Standard Dates
PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) Sep 16, 2019 Standard Dates
PAR-19-339 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Sep 9, 2019 Oct 9, 2019;

Jun 10, 2020;

Oct 14, 2020;

Jun 9, 2021;

Oct 13, 2021;

Jun 8, 2022

PAR-19-340 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Sep 9, 2019 Oct 9, 2019;

Jun 10, 2020;

Oct 14, 2020;

Jun 9, 2021;

Oct 13, 2021;

Jun 8, 2022

RFA-OD-19-021 Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) Sep 9, 2019 Oct 8, 2019;

Aug 7, 2020;

Mar 8, 2021

RFA-OD-19-022 Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) Sep 9, 2019 Oct 8, 2019;

Jul 20, 2020;

Mar 8, 2021

PAR-19-269 Cognitive Systems Analysis of Alzheimer’s Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) Sep 5, 2019 Standard Dates
PAR-19-297 Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) Sep 5, 2019 Standard Dates
PAR-19-298 Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) Sep 5, 2019 Standard Dates
PAR-19-289 Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Sep 5, 2019 Standard Dates
PAR-19-302 NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Sep 5, 2019 Standard Dates
PAR-19-368 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Sep 5, 2019 Standard Dates
PAR-19-325 Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Aug 30, 2019 Sep 30, 2019;

Feb 11, 2020;

Sep 30, 2020;

Feb 11, 2021;

Sep 20, 2021;

Feb 11, 2022

RFA-MH-20-135 BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) Aug 27, 2019 Sep 27, 2019 and

Sep 30, 2020

RFA-MH-20-120 BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Aug 6, 2019 Sep 6, 2019 and

Jun 11, 2020

RFA-EB-19-002 BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial Not Allowed) Aug 3, 2019 Sep 3, 2019;

Sep 3, 2020;

Sep 3, 2021

RFA-MH-20-310 BRAIN Initiative: Non-Invasive Neuromodulation – New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional) Aug 3, 2019 Sep 3, 2019;

Feb 14, 2020

PAR-19-220 Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) Jul 14, 2019 Aug 14, 2019;

Feb 19, 2020;

Aug 19, 2020;

Feb 17, 2021;

Aug 18, 2021;

Feb 16, 2022

PAR-19-212 Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) Jun 23, 2019 Jul 23, 2019;

Mar 23, 2020;

Jul 23, 2020;

Mar 23, 2021;

Jul 23, 2021;

Mar 23, 2022

PAR-19-213 Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional) Jun 23, 2019 Jul 23, 2019;

Mar 23, 2020;

Jul 23, 2020;

Mar 23, 2021;

Jul 23, 2021;

Mar 23, 2022

RFA-AI-19-030 Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed) Jun 21, 2019 Jul 22, 2019
RFA-OD-19-019 Tobacco Regulatory Science (R01  Clinical Trial Optional) Jun 19, 2019 Jul 19, 2019;

Feb 13, 2020;

Jul 17, 2020;

Feb 13, 2021

PAR-19-287 Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Jun 15, 2019 Jul 15, 2019;

Nov 15, 2019;

Jul 10, 2020;

Nov 17, 2020;

Jul 9, 2021;

Nov 15, 2021

PAR-19-264 Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Jun 10, 2019 Jul 10, 2019;

Dec 10, 2019;

Jul 10, 2020;

Dec 10, 2020;

Jul 9, 2021;

Dec 10, 2021

PAR-19-251 Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) Jun 2, 2019 Jul 2, 2019;

Nov 6, 2019;

Jul 2, 2020;

Nov 6, 2020;

Jul 8, 2021;

Nov 8, 2021

PAR-19-252 Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) Jun 2, 2019 Jul 2, 2019;

Nov 6, 2019;

Jul 2, 2020;

Nov 6, 2020;

Jul 8, 2021;

Nov 8, 2021

PAR-19-261 Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) Jun 1, 2019 Jul 1, 2019;

Dec 16, 2019;

May 1, 2020;

Dec 15, 2020;

May 3, 2021;

Dec 13, 2021

PAR-19-279 Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) 30 days after

May 13, 2019

Jul 15, 2019;

Nov 15, 2019;

Jul 15, 2020;

Nov 15, 2020

PAR-19-280 Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) 30 days after

May 13, 2019

Jul 15, 2019;

Nov 15, 2019;

Jul 15, 2020;

Nov 15, 2020

PAR-19-247 Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed) May 18, 2019 Jun 18, 2019;

Jun 18, 2020;

Jun 18, 2021

PA-19-237 Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-163 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-173 Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-184 Biology of Bladder Cancer (R21 Clinical Trial Optional) May 16, 2019 Standard Dates
PAR-19-194 Microbial-based Cancer Therapy – Bugs as Drugs (R21 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-231 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-260 NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
PAR-19-275 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) May 16, 2019 Standard Dates
PAR-19-276 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) May 16, 2019 Standard Dates
RFA-CA-19-038 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) May 11, 2019 Jun 11, 2020;

Nov 20 2020

RFA-CA-19-039 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) May 11, 2019 Jun 11, 2020;

Nov 20 2020

RFA-CA-19-040 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) May 11, 2019 Jun 11, 2020;

Nov 20 2020

RFA-CA-19-041 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) May 11, 2019 Jun 11, 2020;

Nov 20 2020

PAR-19-198 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) May 10, 2019 Jun 10, 2019;

Nov 6, 2019;

Jun 10, 2020;

Nov 6 2020;

Jun 10, 2021;

Nov 8, 2021

PAR-19-199 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) May 10, 2019 Jun 10, 2019;

Nov 6, 2019;

Jun 10, 2020;

Nov 6 2020;

Jun 10, 2021;

Nov 8, 2021

PAR-19-248 Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed) May 10, 2019 Jun 10, 2019;

Jun 10, 2020;

Jun 10,2021

PAR-19-274 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) May 8, 2019 Standard Dates
PAR-19-277 Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) May 8, 2019 Jun 7, 2019;

Oct 8, 2019;

Jun 8, 2020;

Oct 8, 2020;

Jun 8, 2021;

Oct 8, 2021

PAR-19-183 Biology of Bladder Cancer (R01 Clinical Trial Optional) May 5, 2019 Standard Dates
PAR-19-193 Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) May 5, 2019 Standard Dates
PAR-19-162 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) May 5, 2019 Standard Dates
PAR-19-172 Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) May 5, 2019 Standard Dates
PAR-19-234 Limited Competition: Additional Sequencing for the Alzheimer’s Disease Sequencing Project (U01 Clinical Trial Not Allowed) May 5, 2019 Standard Dates
PAS-19-210 Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed) May 5, 2019 Standard Dates
PAR-19-209 Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apr 6, 2019 May 6, 2019;

May 6, 2020;

May 6, 2021

RFA-MH-20-110 Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) Apr 2, 2019 May 2, 2019;

Jan 2, 2020

PAR-18-951 Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed) Mar 15, 2019 Apr 15, 2019;

Apr 15, 2020;

Apr 15, 2021

PAR-19-190 Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional Mar 1, 2019 May 1, 2019, by 11:59 PM Eastern Time.

Apr 4, 2020, by 11:59 PM Eastern Time.

Apr 5, 2021, by 11:59 PM Eastern Time.

RFA-CA-19-033 Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) Feb 15, 2019 Mar 15, 2019;

and Jan 3, 2020

PAR-19-070 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) Feb 11, 2019 Mar 11, 2019;

Jul 9, 2019;

Nov 12, 2019;

Mar 11, 2020;

Jul 9, 2020;

Nov 12, 2020;

Mar 11, 2021;

Jul 9, 2021;

and Nov 12, 2021

PAR-19-071 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) Feb 11, 2019 Mar 11, 2019;

Jul 9, 2019;

Nov 12, 2019;

Mar 11, 2020;

Jul 9, 2020;

Nov 12, 2020;

Mar 11, 2021;

Jul 9, 2021;

and Nov 12, 2021

PA-18-939 Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-18-943 Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-18-944 Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-18-946 Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-19-020 Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-024 Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-19-046 Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-19-053 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-054 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Jan 16, 2019 Standard Dates
PA-19-066 Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-068 Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-073 Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PA-19-081 Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-092 NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) Jan 16, 2019 Standard Dates
PA-19-095 Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PA-19-111 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PAR-19-147 Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) Jan 16, 2019 Standard Dates
PAR-19-146 Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PAR-19-058 Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) Jan 16, 2019 Standard Dates
PAR-19-069 Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 – Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PAR-19-079 Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Jan 16, 2019 Standard Dates
PAR-18-913 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Jan 11, 2019 Feb 11, 2019;

Aug 14, 2019;

Feb 11, 2020;

Aug 11, 2020

PAR-19-159 Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Jan 8, 2019 Standard Dates
PAR-19-158 Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Jan 8, 2019 Standard Dates
PAR-19-157 Bioengineering Research Partnerships (U01 Clinical Trial Required) Jan 8, 2019 Standard Dates
PAR-19-156 Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) Jan 8, 2019 Standard Dates
PAR-19-153 End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Jan 8, 2019 Standard Dates
PAR-19-150 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Jan 8, 2019 Standard Dates
PAR-19-149 Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21 Clinical Trial Not Allowed) Jan 8, 2019 Standard Dates
PA-19-077 Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) Jan 6, 2019 Standard Dates
PAR-19-113 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PAS-19-097 Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard AIDS Dates
PA-18-907 New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-18-908 New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-18-937 Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PA-18-945 Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PA-19-023 Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PA-19-047 Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PA-19-055 Research Project Grant (Parent R01 Clinical Trial Required) Jan 5, 2019 Standard Dates
PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-19-067 Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-19-074 Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PA-19-080 Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-19-094 Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PA-19-112 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PAR-18-919 Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PAR-18-930 Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) Jan 5, 2019 Standard Dates
PAR-19-045 End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
PAR-19-057 Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) Jan 5, 2019 Standard Dates
RFA-MH-19-400 BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) Jan 4, 2019 Feb 4, 2019;

Oct 9, 2019;

Oct 9, 2020

PA-19-096 Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) Jan 4, 2019 Standard Dates
PAR-19-044 End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21 Clinical Trial Optional) Jan 4, 2019 Standard Dates
PAR-19-078 Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) Jan 4, 2019 Standard Dates
PAR-19-101 Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) Dec 30, 2018 Jan 30, 2019;

Jul 30, 2019;

Jan 30, 2020;

Jul 30, 2020

RFA-MH-19-148 BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) Dec 22, 2018 Jan 22, 2019;

Jan 24, 2020

RFA-MH-19-149 BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed) Dec 22, 2018 Jan 22, 2019;

Jan 24, 2020

PAS-18-915 HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) Dec 7, 2018 Standard AIDS Dates
PA-18-917 Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 – Clinical Trial Optional) Dec 7, 2018 Standard Dates
PA-19-042 Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) Dec 7, 2018 Standard AIDS Dates
PA-19-050 Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) Dec 7, 2018 Standard AIDS Dates
PAR-18-895 CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) Dec 7, 2018 Jan 7, 2019;

Jan 7, 2020;

Jan 7, 2021

RFA-MH-19-242 Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Dec 3, 2018 Jan 3, 2019;

Nov 20, 2019;

Nov 20, 2020

PAR-18-884 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 – Clinical Trial Not Allowed) Nov 4, 2018 Dec 4, 2018;

Dec 4, 2019;

Dec 4, 2020

PAR-18-885 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 – Clinical Trial Not Allowed) Nov 4, 2018 Dec 4, 2018;

Dec 4, 2019;

Dec 4, 2020

PAR-18-879 Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional) Nov 2, 2018 Dec 3, 2018;

Dec 3, 2019;

Dec 3, 2020

PAR-18-929 High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) Oct 21, 2018 Nov 21, 2018 then Standard dates apply
RFA-MH-19-240 Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Oct 20, 2018 Nov 20, 2018;

Nov 20, 2019;

Nov 20, 2020;

PAR-18-830 The Role of Epitranscriptomics in Development and Disease (R01 – Clinical Trial Not Allowed) Oct 7, 2018 Nov 7, 2018;

Jun 3, 2019;

Mar 3, 2020;

Nov 7, 2020;

Jun 3, 2021

PAR-18-869 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Oct 7, 2018 Nov 7, 2018;

Mar 6, 2019;

Nov 7, 2019;

Mar 6, 2020

PA-18-718 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PA-18-824 Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PA-18-826 Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PA-18-839 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) Sep 16, 2018 Standard Dates
PA-18-850 Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) Sep 16, 2018 Standard Dates
PA-18-858 Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PA-18-867 Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PA-18-872 Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PAR-18-788 Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PAR-18-857 Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Sep 16, 2018 Standard Dates
PAR-18-892 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Sep 16, 2018 Standard Dates
PA-18-719 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-776 Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-823 Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-825 Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-838 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-849 Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-856 Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-859 Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-861 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 – Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-862 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 – Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-863 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 – Clinical Trial Optional) Sep 5, 2018 Standard Dates
PA-18-868 Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-873 Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PA-18-902 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional Sep 5, 2018 Standard Dates
PAR-18-766 Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 – Clinical Trial Optional) Sep 5, 2018 Standard Dates
PAR-18-787 Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Sep 5, 2018 Standard Dates
PAR-18-820 Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PAR-18-877 Early Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PAR-18-878 Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) Sep 5, 2018 Standard Dates
PAR-18-893 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PAR-18-896 NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) Sep 5, 2018 Standard Dates
PAR-18-860 Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed) Sep 4, 2018 Oct 15, 2018;

Jun 14, 2019;

Feb 14, 2020;

Oct 15, 2020

PAR-18-777 Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) Sep 2, 2018 Oct 2, 2018;

Oct 2, 2019;

Oct 2, 2020

PAR-18-778 Novel Genomic Technology Development, (R21 Clinical Trial Not Allowed) Sep 2, 2018 Oct 2, 2018;

Oct 2, 2019;

Oct 2, 2020

RFA-MH-19-136 BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) Aug 27, 2018 Sep 27, 2018;

Sep 6, 2019;

Sep 9, 2020

PA-18-753 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) Aug 7, 2018 Standard AIDS Dates
PA-18-754 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed) Aug 7, 2018 Standard AIDS Dates
PAR-18-764 Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Aug 7, 2018 Standard AIDS Dates
PAR-18-822 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed) Aug 4, 2018 Sep 4, 2018;

Sep 4, 2019;

Sep 4, 2020

PAR-18-789 Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) Jul 21, 2018 Aug 21, 2018;

Mar 19, 2019;

Aug 21, 2019;

Mar 19, 2020;

Aug 21, 2020;

Mar 19, 2021

RFA-MH-19-200 Rare Genetic Disorders as a Window into the Genetic Architecture of Mental Disorders (U01 Clinical Trial Not Allowed) Jul 9, 2018 Aug 9, 2018;

Sep 6, 2019;

Sep 9,2020

RFA-MH-19-201 Rare Genetic Disorders as a Window into the Genetic Architecture of Mental Disorders (Collaborative U01 Clinical Trial Not Allowed) Jul 9, 2018 Aug 9, 2018;

Sep 6, 2019;

Sep 9, 2020

RFA-NS-18-030 BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) Jun 3, 2018 Jul 3, 2018;

Nov 6, 2018;

Jul 3, 2019;

Nov 6, 2019;

Jul 1, 2020;

Nov 10, 2020

RFA-HG-18-001 Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) May 27, 2018 Jun 27, 2018;

Jun 27, 2019;

Jun 26, 2020

RFA-HG-18-002 Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) May 27, 2018 Jun 27, 2018;

Jun 27, 2019;

Jun 26, 2020

PAR-18-654 Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) May 19, 2018 Jun 19, 2018;

Nov 19, 2018;

Jun 18, 2019;

Nov 19, 2019;

Jun 18, 2020;

Nov 19, 2020

PAR-18-655 Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) May 19, 2018 Jun 19, 2018;

Nov 19, 2018;

Jun 18, 2019;

Nov 19, 2019;

Jun 18, 2020;

Nov 19, 2020

PA-18-571 Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-572 Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-602 Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-620 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 – Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-623 Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PA-18-687 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-723 Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-724 Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PA-18-728 Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-739 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PA-18-741 Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PAR-18-659 Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PAR-18-690 Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional) May 16, 2018 Standard Dates
PAR-18-691 Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PAR-18-733 Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 – Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PAR-18-734 Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 – Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PAR-18-743 Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PAR-18-744 Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) May 16, 2018 Standard Dates
PAR-18-760 In Vivo Synaptic Function in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed) May 16, 2018 Standard Dates
PA-18-773 International Research Collaboration on Drug Abuse and Addiction Research May 9, 2018 Standard Dates
PA-18-570 Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-603 Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-619 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-622 Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) May 5, 2018 Standard Dates
PA-18-660 Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) May 5, 2018 Standard Dates
PA-18-688 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-722 Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-725 Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed) May 5, 2018 Standard Dates
PA-18-729 Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PA-18-738 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) May 5, 2018 Standard Dates
PAR-18-616 Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) May 5, 2018 Standard Dates
PAR-18-689 Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 – Clinical Trial Optional) May 5, 2018 Standard Dates
PAR-18-706 Selective Cell and Network Vulnerability in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed) May 5, 2018 Standard Dates
PA-18-615 Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional) Apr 7, 2018 Standard Dates
PA-18-651 Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) Apr 7, 2018 Standard Dates
PA-18-652 Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed) Apr 7, 2018 Standard Dates
PA-18-695 Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed) Apr 7, 2018 Standard Dates
PA-18-699 Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed) Apr 7, 2018 Standard Dates
RFA-EY-18-001 BRAIN Initiative: New Concepts and Early – Stage Research for Large – Scale Recording and Modulation in the Nervous System (R21 Clinical Trial Not Allowed) Apr 1, 2018 May 1, 2018;

Oct 29, 2018;

May 1, 2019;

Oct 29, 2019;

May 1, 2020;

Oct 29, 2020

PAR-18-664 Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional) Mar 17, 2018 Apr 17, 2018;

Jul 18, 2018;

Feb, 14, 2019;

Jul 18, 2019;

Feb 14, 2020;

Jul 20, 2020

PAR-18-433 NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) Jan 25, 2018 Standard Dates
PA-18-078 Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) Jan 17, 2018 Standard Dates
PA-18-532 Early-life Factors and Cancer Development Later in Life (R21 Clinical Trial Not Allowed) Jan 16, 2018 Standard Dates
PA-18-438 Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional) Jan 9, 2018 Standard Dates
PA-18-568 International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) Jan 9, 2018 Standard Dates
PAR-18-561 NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 Clinical Trial Optional) Jan 9, 2018 Standard Dates
PA-18-060 Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) Jan 6, 2018 Standard Dates
PA-18-377 Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional) Jan 5, 2018 Standard Dates
PA-18-569 Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01 Clinical Trial Optional) Jan 5, 2018 Standard Dates
PAS-18-557 Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 Clinical Trial Optional) Jan 5, 2018 Standard Dates